Report examines influenza, Tdap, and COVID-19 vaccination coverage and hesitancy in pregnant women

An observational report from the United States examined influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant women. The study design, specific intervention or comparator, and sample size were not reported. The report did not provide primary or secondary outcomes, follow-up duration, or any quantitative results regarding vaccination rates or hesitancy levels.

No safety or tolerability data, including adverse events, serious adverse events, or discontinuations, were reported. The report also did not detail specific study limitations, funding sources, or potential conflicts of interest.

Given the lack of reported data on study methods, results, and safety, the clinical practice relevance of this report is unclear. It identifies a topic of interest—vaccination in pregnancy—but does not provide actionable evidence. Clinicians should seek more robust, peer-reviewed studies with complete methodological details and results to inform vaccination counseling for this population.